1. Xia, Kezhou, Zheng, Di, Wei, Zhun, Liu, Wenda, Guo, Weichun. 2023. TRIM26 inhibited osteosarcoma progression through destabilizing RACK1 and thus inactivation of MEK/ERK signaling. In Cell death & disease, 14, 529. doi:10.1038/s41419-023-06048-9. https://pubmed.ncbi.nlm.nih.gov/37591850/
2. Sun, Yuening, Lin, Peng, Zhou, Xiumin, Xu, Xiaofeng, Mao, Xinliang. 2023. TRIM26 promotes non-small cell lung cancer survival by inducing PBX1 degradation. In International journal of biological sciences, 19, 2803-2816. doi:10.7150/ijbs.81726. https://pubmed.ncbi.nlm.nih.gov/37324936/
3. Sharma, Mona, Liu, Ke, Wei, Jianchao, Ma, Zhiyong, Qiu, Yafeng. 2024. Mechanistic Role of TRIM26 in Viral Infection and Host Defense. In Genes, 15, . doi:10.3390/genes15111476. https://pubmed.ncbi.nlm.nih.gov/39596676/
4. Zhang, Mingjiao, Tan, Haiqi, Gong, Yibing, Zheng, Lei, Lyu, Xiaoming. . TRIM26 restricts Epstein-Barr virus infection in nasopharyngeal epithelial cells through K48-linked ubiquitination of HSP-90β. In FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 38, e23345. doi:10.1096/fj.202300929RR. https://pubmed.ncbi.nlm.nih.gov/38038978/
5. Liang, Yisha, Zhang, Guigen, Li, Qiheng, Wei, Wensheng, Zhong, Jin. 2021. TRIM26 is a critical host factor for HCV replication and contributes to host tropism. In Science advances, 7, . doi:10.1126/sciadv.abd9732. https://pubmed.ncbi.nlm.nih.gov/33523994/
智鼠故事 
